Chyong-Huey Lai Selected Research

Chyong-Huey Lai Research Topics

Disease

66	Neoplasms (Cancer) 04/2024 - 04/2002
38	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2024 - 02/2003
26	Endometrial Neoplasms (Endometrial Cancer) 02/2022 - 04/2002
21	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 01/2006
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 01/2004
13	Carcinoma (Carcinomatosis) 10/2023 - 04/2002
11	Neoplasm Metastasis (Metastasis) 11/2021 - 07/2003
6	Lymphatic Metastasis 11/2021 - 10/2004
6	Adenocarcinoma 09/2016 - 04/2002
5	Infections 11/2016 - 01/2007
4	Ovarian Epithelial Carcinoma 10/2022 - 06/2006
4	Adenosquamous Carcinoma 12/2016 - 06/2011
4	Uterine Cervical Dysplasia 07/2012 - 04/2004
3	Endometrial Hyperplasia 02/2022 - 02/2006
3	Papillomavirus Infections 01/2021 - 03/2006
3	Fever (Fevers) 10/2009 - 08/2002
2	Hypoxia (Hypoxemia) 11/2023 - 01/2008
2	Peritoneal Neoplasms 12/2022 - 12/2021
2	Pathologic Complete Response 09/2022 - 12/2006
2	Disease Progression 07/2021 - 12/2014
2	Carcinogenesis 01/2021 - 02/2013
2	Leiomyosarcoma 01/2020 - 01/2006
2	Choriocarcinoma 05/2010 - 08/2002
2	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 02/2007 - 01/2006
1	Hyperandrogenism 11/2023
1	Virilism (Virilization) 11/2023
1	Lung Neoplasms (Lung Cancer) 10/2023
1	Hyperplasia 02/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 09/2023 - 11/2005
11	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 04/2004
9	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 10/2003
8	Biomarkers (Surrogate Marker)IBA 02/2022 - 09/2010
7	Tumor Biomarkers (Tumor Markers)IBA 12/2023 - 10/2004
6	RNA (Ribonucleic Acid)IBA 11/2023 - 11/2005
6	PhosphoproteinsIBA 01/2021 - 09/2010
5	Formaldehyde (Formol)FDA Link 11/2023 - 05/2010
5	ParaffinIBA 11/2023 - 05/2010
5	VaccinesIBA 01/2021 - 07/2006
5	squamous cell carcinoma-related antigenIBA 11/2010 - 07/2004
4	PlatinumIBA 05/2024 - 06/2006
4	AntigensIBA 11/2021 - 07/2006
4	Estrogen ReceptorsIBA 07/2019 - 04/2002
4	Hormones (Hormone)IBA 09/2016 - 04/2002
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2024 - 12/2016
3	MicroRNAs (MicroRNA)IBA 02/2022 - 05/2010
3	NucleophosminIBA 01/2021 - 02/2013
3	Cisplatin (Platino)FDA LinkGeneric 06/2017 - 03/2010
3	Estrogens (Estrogen)FDA Link 09/2016 - 01/2013
3	Phosphotransferases (Kinase)IBA 09/2014 - 08/2012
3	Glucose (Dextrose)FDA LinkGeneric 08/2014 - 01/2004
3	Megestrol Acetate (Borea)FDA LinkGeneric 05/2014 - 04/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2009 - 08/2002
3	DNA VaccinesIBA 12/2007 - 07/2006
2	Peptides (Polypeptides)IBA 12/2023 - 08/2016
2	SteroidsIBA 11/2023 - 02/2013
2	pembrolizumabIBA 10/2023 - 09/2021
2	Immune Checkpoint InhibitorsIBA 10/2023 - 10/2021
2	Progestins (Progestagens)IBA 09/2022 - 02/2006
2	palbociclibIBA 11/2021 - 07/2019
2	Hematoxylin (Haematoxylon)IBA 10/2021 - 01/2004
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2021 - 01/2004
2	Bevacizumab (Avastin)FDA Link 07/2021 - 01/2017
2	OligonucleotidesIBA 01/2021 - 03/2016
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 09/2014
2	Acetates (Acetic Acid Esters)FDA Link 07/2019 - 09/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 09/2016 - 04/2002
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2016 - 08/2012
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2013 - 04/2002
2	Tamoxifen FDA LinkGeneric 01/2013 - 04/2002
2	activin receptor type II-A (activin A receptor, type II)IBA 01/2013 - 08/2012
2	Hemoglobins (Hemoglobin)IBA 06/2011 - 01/2008
2	Codon (Codons)IBA 01/2007 - 07/2006
2	liposomal doxorubicin (Doxil)FDA Link 06/2006 - 09/2004
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2006 - 02/2004
1	Pyruvic Acid (Pyruvate)IBA 04/2024
1	Nucleic AcidsIBA 11/2023
1	Circulating Tumor DNAIBA 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	atezolizumabIBA 10/2023
1	durvalumabIBA 10/2023
1	B7-H1 AntigenIBA 10/2023

Therapy/Procedure

27	Therapeutics 05/2024 - 04/2002
16	Drug Therapy (Chemotherapy) 05/2024 - 08/2002
14	Radiotherapy 04/2024 - 12/2003
12	Chemoradiotherapy 01/2024 - 09/2004
12	Salvage Therapy 07/2021 - 02/2004
11	Hysterectomy 02/2024 - 04/2002
7	Adjuvant Chemotherapy 11/2021 - 01/2006
6	Cytoreduction Surgical Procedures 12/2022 - 11/2017
6	Aftercare (After-Treatment) 04/2020 - 02/2007
5	Laparotomy 05/2024 - 11/2005
5	Lymph Node Excision (Lymph Node Dissection) 03/2021 - 11/2009
3	Immunotherapy 12/2023 - 12/2007
3	Hyperthermic Intraperitoneal Chemotherapy 12/2022 - 12/2021
3	Neoadjuvant Therapy 07/2021 - 02/2007
3	Adjuvant Radiotherapy 06/2017 - 10/2004
3	Conservative Treatment 03/2011 - 05/2005
2	Immunomodulation 04/2015 - 07/2011
2	Combination Drug Therapy (Combination Chemotherapy) 03/2010 - 08/2002
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2023